posted on 7 May 2008 2:17PM EST
Fact: the FDA relies on user fees since the 1990s with the goal of speeding up drug approvals, meaning it is severely underfunded by the federal government and has not been able to fulfill it's mission based on that alone...
NOW the FDA wants to fill more than 1,300 posts in the upcoming months (
posted on 30 April 2008 2:15PM EST
Barack Obama needs to set straight the facts about the transmission of the AIDS virus that his pastor, Jeremiah Wright, said was an attempt by the United States government to wipe out people of color. It is not enough for Senator Obama to distance himself from Jeremiah Wright’s accusation or denounce him; there is an important distinction between being outraged and setting the record straight about how the virus has been and is transmitted. Senator Obama has not done that, and he has a responsibility to this generation and to the generations that follow to put forth these facts.
There ...more.
posted on 28 April 2008 11:37PM EST
Recently, global food shortages (including riots in Thailand, Egypt and other places) have prompted a serious question: “What is the biotech/pharma industry doing in terms of generating higher yield grains?”
I have not heard of new seedstock being introduced what with the abnormal aversion to genetically engineered strains (a public misconception that needs some serious addressing) in the US and Europe. Generally speaking, the agri-biotech industry has been laying low and not addressing the need for a) high-yield seedstock and b) cleaning up the image. The French government has passed a ...more.
posted on 23 April 2008 2:37PM EST
The National Institutes of Health (NIH) has an annual budget of over $28 billion. Only 10% of the NIH’s budget supports projects conducted by nearly 6,000 scientists in its own laboratories, most of which are on the NIH campus in Bethesda. In terms of extramural funding, in FY 2007, out of 47,455 grant requests, only 10,100 were funded, barely over 20%. That is less than $4 billion of its $28 billion budget.
According to prepared testimony given by Harvard 's president, Dr. Drew Faust, before the Senate Committee on Health, Education, Labor and Pensions last month, “The responses ...more.
posted on 16 April 2008 3:33PM EST
Bioenergy is all the rage. I would like to play devil 's advocate and point out some similarities with past trends in science.
Chances are, if you are writing a grant proposal or want to start a company and mention bioenergy, you'll get funding. Clearly this is an oversimplification, but following the money leads to a lot of new bioenergy projects being started (link). This reminds me of the genomics boom of the mid- to late 1990s: a lot of hype, great promise (personalized medicine anybody?), and ...more.
pages: 1 2 3 4 5 6 7 8 9 10 >>
NOTICE: As such, the comments on this blog were, are, and will always be solely the opinions of the individuals leaving them. In no way does Genetic Engineering & Biotechnology News, GEN Publishing, Inc., or Mary Ann Liebert ,Inc. endorse, condone, agree with, sponsor, etc. these comments.
INTERVIEW:
GENE THERAPY FOR FATAL NEURODEGENERATIVE DISEASE IN CHILDREN - Interview with Ronald G. Crystal, M.D., Professor and Chairman of the Department of Genetic Medicine of the Weill Medical College of Cornell University
...more
ADVERTISEMENT
NewsArticles Blogs
Subscribe to RSS
HOME
Hot Topics
All Topics
Archived
Post a Topic
RSS
Listen
Save
Comment